DMA (Destra Multi-Alternative Fund) Research & Development: $0.00 Mil (TTM As of Mar. 2026)


DMA Destra Multi-Alternative Fund DMA
34 GF Score
Price $7.33
! 1 Warning Sign
View Full Analysis

What is Destra Multi-Alternative Fund Research & Development?

Destra Multi-Alternative Fund DMA 34 Research & Development is $0.00 Mil as of Mar. 2026. GuruFocus rates DMA with a GF Score™ of 34/100. The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Destra Multi-Alternative Fund's Research & Development for the six months ended in Mar. 2026 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $0.00 Mil.

Destra Multi-Alternative Fund  (NYSE:DMA) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Destra Multi-Alternative Fund Research & Development Related Terms

Destra Multi-Alternative Fund Research & Development Historical Data

* Premium members only.

The historical data trend for Destra Multi-Alternative Fund's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Destra Multi-Alternative Fund Research & Development Chart

Destra Multi-Alternative Fund Annual Data
Trend Feb22 Mar23 Mar24 Mar25 Mar26
Research & Development
0.00 0.00 0.00 0.00 0.00

Destra Multi-Alternative Fund Semi-Annual Data
Aug21 Feb22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
DMA
34GF Score
Destra Multi-Alternative Fund DMA
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Destra Multi-Alternative Fund Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.00 Mil mean?
Destra Multi-Alternative Fund (DMA) has a Research & Development of $0.00 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Destra Multi-Alternative Fund and its competitors.
Is Destra Multi-Alternative Fund's Research & Development too high?
Destra Multi-Alternative Fund's current Research & Development is $0.00 Mil. Overall, Destra Multi-Alternative Fund has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Destra Multi-Alternative Fund's Research & Development compare to PGZ and CCIF?
Destra Multi-Alternative Fund's Research & Development of $0.00 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Asset Management company?
A good Research & Development depends on the Asset Management industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Destra Multi-Alternative Fund and its competitors. Destra Multi-Alternative Fund's current Research & Development is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Destra Multi-Alternative Fund stock overvalued right now?
Destra Multi-Alternative Fund (DMA) has a current Research & Development of $0.00 Mil. The current Research & Development is $0.00 Mil. Destra Multi-Alternative Fund's overall GF Score™ is 34/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Destra Multi-Alternative Fund (DMA), the current Research & Development is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Destra Multi-Alternative Fund Business Description

Address 443 North Willson Avenue, Bozeman, MT, USA, 59715
Destra Multi-Alternative Fund is a non-diversified, closed-end management investment company that operates as an interval fund with a continuous offering of fund shares. The investment objective of the fund is to seek returns from capital appreciation and income, with an emphasis on income generation. The Fund pursues its investment objective by investing mainly in the income-producing securities of real estate investment trusts (REITs) and alternative investment funds, as well as common stocks and structured notes, bonds, and asset-backed securities.
34GF Score

Get the complete analysis for DMA

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.33
Price